Table of Contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 26, 2004
CALIPER LIFE SCIENCES, INC.
Delaware | 0-28229 | 33-0675808 | ||
(State of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
68 Elm Street
Hopkinton, MA 01748
(508) 435-9500
Item 12. Results of Operations and Financial Condition. | ||||||||
SIGNATURES | ||||||||
EXHIBIT INDEX | ||||||||
Ex-99.1 Press release, dated February 26, 2004 |
Table of Contents
Item 12. Results of Operations and Financial Condition.
On February 26, 2004, Caliper Life Sciences, Inc. issued a press release announcing financial results for the quarter and year ended December 31, 2003. A copy of this press release is attached hereto as Exhibit 99.1 and is incorporated herein by reference.
Table of Contents
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
CALIPER LIFE SCIENCES, INC. | ||||
By: | /s/ JAMES L. KNIGHTON | |||
James L. Knighton | ||||
February 26, 2004 | Chief Operating Officer and Chief Financial Officer |